Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis
Authors:
- 20 September 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (15) , 1664-1673
Abstract
BACKGROUND The ARCaP cell line was established from the ascites fluid of a patient with metastatic prostate cancer. This study characterized the host microenvironmental role in cancer progression, epithelial to mesenchymal transition (EMT), and bone and adrenal metastasis in parental ARCaP and its derived cell subclones. METHODS Cytogenetic profiles, growth, migration, invasion, cellular interaction, drug sensitivities, and gene expression of ARCaP cell subclones were compared. In vivo gene expression, behavior, and metastasis of ARCaP subclones were analyzed by serial intracardiac injections into SCID mice. RESULTS ARCaPE cells, with cobblestone morphology, underwent EMT through cellular interaction with host bone and adrenal gland. Lineage-derived ARCaPM cells, with spindle-shape fibroblastic morphology, exhibited decreased cell adhesion and increased metastasis to bone and adrenal gland. Cytogenetic analyses of parental and ARCaP subclones confirmed their clonality. CONCLUSIONS ARCaP uniquely models the molecular basis of prostate cancer bone and adrenal metastases and epithelial to mesenchymal transition. Prostate 66: 1664–1673, 2006.Keywords
This publication has 40 references indexed in Scilit:
- In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate TumorsClinical Cancer Research, 2005
- Wnt signalling in stem cells and cancerNature, 2005
- Bi‐directional interactions of prostate cancer cells and bone marrow endothelial cells in three‐dimensional cultureThe Prostate, 2005
- MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENTJournal of Urology, 2005
- The basement membrane protein laminin-5 acts as a soluble cell motility factorExperimental Cell Research, 2004
- LuCaP 35: A new model of prostate cancer progression to androgen independenceThe Prostate, 2003
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 casesVirchows Archiv, 2001
- Androgens and growth factors in prostate cancer: a transgenic perspectiveProstate Cancer and Prostatic Diseases, 2000
- LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasisThe Prostate, 2000